The ThinkCancer! Feasibility Study

Cancer Clinical Trial

Official title:

The ThinkCancer! Intervention: Protocol for a Feasibility Study Incorporating a Randomised Pilot Trial With an Embedded Process and Economic Evaluation

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04823559
• Other study ID #: UWalesBangor
• Status: Recruiting
• Phase: N/A
• Start date: February 5, 2020
• Est. completion date: August 2021

Study information

• Verified date: March 2021
• Source: Bangor University
• Contact: Jessica L Roberts, BSc, PhD
• Phone: 01248 383516
• Email: j.l.roberts[@]bangor.ac.uk
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Background Wales, like other UK countries, has relatively poor cancer outcomes. Late diagnosis and a slow referral process are major contributors. General practitioners (GPs) and other care providers working in primary care are often faced with patients presenting with a multitude of non-specific symptoms that could be cancer. Safety netting can be used to manage diagnostic uncertainty by ensuring patients with vague symptoms are appropriately monitored. The ThinkCancer! Workshop is an educational behaviour change intervention aimed at the whole general medical practice team, designed to improve primary care approaches to ensure timely diagnosis of cancer. The workshop will consist of teaching and awareness sessions, appointment of a Safety Netting Champion and the development of a bespoke Safety Netting Plan. This study aims to assess the feasibility of the ThinkCancer! Intervention for a future definitive randomised controlled trial, in terms of recruitment, randomisation, retention, acceptability, adherence and barriers to the intervention. Methods The ThinkCancer! study is a randomised, multisite feasibility trial, with an embedded process evaluation and economic evaluation. Twenty-three to 30 general medical practices will be recruited across Wales, randomised in a ratio of 2:1 of intervention versus control who will follow usual care. The workshop will be delivered by a GP educator, and will be adapted iteratively throughout the trial period. Baseline practice characteristics will be collected via questionnaire. We will also collect Primary Care Interval (PCI), Two Week Wait (2WW) referral rate, conversion rate and detection rate at baseline and six months post-randomisation. Participant feedback, researcher reflective notes and economic costings will be collected following each workshop. A process evaluation will assess implementation using an adapted Normalisation Measure Development (NoMAD) questionnaire and qualitative interviews. An economic feasibility analysis will inform a future economic evaluation. Discussion This study will allow us to test and further develop a novel evidenced-based complex intervention aimed at general practice teams to expedite the diagnosis of cancer in primary care. The results from this feasibility study will inform the future design of a full-scale definitive phase III trial.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 24
• Est. completion date: August 2021
• Est. primary completion date: August 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Any practices in Wales are eligible for inclusion.

Exclusion Criteria:

• As we intend to include a broad group of general medical practices, there are no formal exclusion criteria. As determining feasibility is the main objective of this study, the eligibility criteria remain broad in order to allow for inclusion of a range of practices, which will aid the intervention refinement and allow for a better understanding on what is feasible in all types of practices and why some practices may not take part.

Related Conditions & MeSH terms

• Cancer

Intervention

Other:
• ThinkCancer workshop
The proposed intervention, the ThinkCancer! Workshop, is practice-based and consists of themed sessions for both clinical and non-clinical staff, the co-production of a Cancer Safety Netting Plan (CSNP) and the appointment of a Cancer Safety Netting Champion (CSNC). The workshop aims to raise awareness and increase knowledge around current cancer diagnosis guidance and will be delivered over half a day during GP protected time in the form of face-to-face educational sessions. Sessions will consist of a series of interactive activities exploring existing processes within practices and developing plans for change to implement each component.

Locations

Country	Name	City	State
United Kingdom	Betsi Cadwaldr University Health Board	Bangor
United Kingdom	Aneurin Bevan University Health Board	Blaenau Gwent
United Kingdom	Hywel Dda University Health Board	Camarthenshire
United Kingdom	Cardiff and Vale University Health Board	Cardiff
United Kingdom	Cwm Taf Morgannwg University Health Board	Cwm Taf
United Kingdom	Powys Teaching Health Board	Powys
United Kingdom	Swansea Bay University Health Board	Swansea

Sponsors (3)

Lead Sponsor	Collaborator
Bangor University	Cancer Research Wales, North Wales Organisation for Randomised Trials in Health

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility of a future definitive trial	Number of practices approached, interested in participating, consented and randomised, retention of recruited practices, ability to collect data	From date of initial expression of interest to participate to end of follow up period (13 months)
Secondary	Two Week Wait referral rate	Number of two week rate referrals made in a given time period, multiplied by 100000 and divided by the practice list size	Six months pre-randomisation and six months post-randomisation
Secondary	Primary Care Interval	The time between the date of first presentation and the date of referral	Six months pre-randomisation and six months post-randomisation